Zusammenfassung
Substitutionsbehandlung ist eine Therapieform, bei welcher die Verschreibung abhängigkeitserzeugender Substanzen als Adjuvans im Rahmen der medizinischen und psychosozialen Betreuung eingesetzt wird. Indikation und Behandlungsdauer werden auf der Grundlage einer individuellen Abklärung festgesetzt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ali R, Auriacombe M, Casas M et al. (1998) Report of the external panel on the evaluation of the Swiss scientific studies of medically prescribed narcotics to drug addicts. WHO, Geneva
Arif A, Westermeyer J (1990) Methadone maintenance in the management of opioid dependence. An international review. Praeger, New York
Arndt JO, McLellan AT, Dorozynsky L, Woody GE, O’Brien CP (1994) Desipramine treatment for cocaine dependence. J Nerv Ment Dis 182:151–156
Ball JC, Ross A (1991) The effectiveness of methadone maintenance treatment. Springer, Berlin Heidelberg New York Tokio
Bammer G, Dobler-Mikola A, Fleming PH, Strang , Uchtenhagen A (1999) The heroin prescribing debate: integrating science and politics. Science 284:1277–1278
Batki SL, Washburu AM, Delucchi K, Jones RT (1996) A controlled trial of Fluoxetine in crack cocaine dependence. Drug Alcohol Depend 41:137–142
Brüssel G van (1995) Le programme de distribution de morphine a Amsterdam: experiences pratiques. In: Rihs-Middel M, Clerc J, Stamm R (eds) La prescription de stupefiants sous contröle medical. Editions Medecine et Hygiene, Geneve, pp 161–167
Bühringer G, Gastpar M, Heinz W et al. (1995) Methadon-Standards. Vorschläge zur Qualitätssicherung bei der Methadonsubstitution im Rahmen der Behandlung von Drogenabhängigen. Enke, Stuttgart
Bundesamt für Gesundheit (1985) Methadonbericht. Suchtmittelersatz in der Behandlung Heroinabhängiger in der Schweiz. Bundesministerium für Gesundheit, Bern
Caplehorn JR (1994) A comparison of abstinence-oriented and indefinite methadone maintenance treatment. Int J Addict 29:1361–1375
Chutuape MA. Silverman K, Stitzer ML (1998) Survey assessment of methadone treatment services reinforcers. Am J Drug Alcohol Abuse 29:1–16
Cooper JR, Altman F, Brown BS, Czechowicz D (1983) Research on the treatment of narcotic addiction. The State of the art. National Institute on Drug Abuse, Rockville
Dees SM, Dansereau DF, Simpson DD (1997) Mapping-enhanced drug abuse counseling: urinalysis results in the first year of methadone treatment. J Subst Abuse Treat 14:45–54
Dolan K, Hall W, Wodak A (1998) The provision of methadone within prison settings. In: Ward J, Mattick RP, Hall W (eds) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam, pp 379–396
Dole V, Nyswander M (1965) A medical treatment for Diacetylmorphine (heroin) addiction. JAMA 193:146–150
Farrell M, Neeleman J, Gossop M, Griffiths P, Buning E, Finch E, Strang J (1996) Drug prevention. A review of the legislation, regulation and delivery of methadone in 12 member states of the European Union. Final Report. Office for Official Publications of the European Communities, Brüssels
Finnegan LP, Hagan T, Kaltenbach KA (1991) Scientific foundation of clinical practice: opiate use in pregnant women. Bull NY Acad Med 67:223–239
Gossop M (1998) NTORS at one year. The national treatment outcome research study. Department of Health, London
Halikas JA, Nugent SM, Crosby RD, Carlson GA (1993) 1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse. J Addict Dis 12:129–139
Hartnoll R, Mitcheson M, Battersby A, Brown G, Ellis M, Fleming P, Hedley N (1980) Evaluation of heroin maintenance in a controlled trial. Arch Gen Psychiatry 37:877–884
Hubbard RL, Marsden ME, Rachal JV, Haarwood HJ, Cavanaugh ER, Ginzburg HM (1989) Drug abuse treatment. A national study of effectiveness. University of North Carolina, Chapel Hill
Kreek MJ (1996) Long-term pharmacotherapy for opiate (primarily heroin) addiction: opioid agonists. In: Schuster CH, Kuhar MJ (eds) Pharmacological aspects of drug dependence. Toward an integrated neurobehavioral approach. Springer, Berlin Heidelberg New York Tokio, pp 487–562
Lifschitz MH, Wilson GS, Smith EO, Desmond MM (1985) Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 75:269–274
Ling W, Klett JC, Gillis RC (1980) A cooperative clinical study of methadyl acetate. Arch Gen Psychiatry 37:908–911
McLellan AT, Arndt IO, Metzger IS, Woody GE, O’Brien CP (1993) The effects of psychosocial services in substance abuse treatment. JAMA 269:1953–1959
Maddux JF, Desmond DP, Esquivel M (1995) Rapid admission and retention on methadone. Am J Drug Alcohol Abuse 21:533–547
Mattick RP, Oliphant D, Ward J, Hall W (1998) The effectiveness of other opioid replacement therapies: LAAM, heroin, buprenorphine, naltrexone and injectable maintenance. In: Ward J, Mattick RP, Hall W (eds) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam, pp 123–160
Metrebian N, Shanahan W, Wells B, Stimson GV (1998) Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions. Med J Aust 168:596–600
Mino A (1990) Analyse scientifique de la literature sur la remise controlee d’heroine ou de morphine. Institutions universitaires de psychiatrie, Geneve
Parrino MW (1991) State methadone treatment guidelines. US Department of Health and Human Services, Rockville
Raschke P (1994) Substitutionstherapie. Ergebnisse langfristiger Behandlung von Opiatabhängigen. Lambertus, Freiburg im Breisgau
Ree JM van (1998) Study on the effectiveness of medically co-prescribed heroin. Progress Report. Central Committee on the Treatment of Heroin Addicts, Utrecht
Rhoades HM, Creson D, Elk R, Schmitz J, Grabowsk J (1998) Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 88:34–39
Robinson GM, Dukes PD, Robinson BJ, Cook RR, Mahoney GN (1993) The misuse of buprenorphine and buprenorphine-naloxone combination in Wellington, New Zealand. Drug Alcohol Depend 33:81–86
Ruel JM (1996) International survey on the use of methadone in the treatment of narcotic addiction. Bureau of Drug Surveillance, Ottawa
Savage C, Karp EG, Curran SF, Hanion TE, McCabe OL (1976) Methadone/LAAM maintenance: a comparison study. Compr Psychiatry 17:415–424
Seidenberg A, Honegger U (1998) Methadon, Heroin und andere Opioide. Medizinisches Manual für die ambulante opioidgestützte Behandlung. Huber, Bern
Senay EC, Uchtenhagen A (1990) Methadone in the treatment of opioid dependence. In: Arif A, Westermeyer J (eds) Methadone maintenance in the management of opioid dependence. Praeger, New York, pp 19–54
Senay EC, Barthwell A, Marks R, Bokos PJ (1994) Medical maintenance: an interim report. J Addict Dis 13:65–69
Simpson £D, Seils SB (1990) Opioid addiction and treatment: a 12-year follow-up. Krieger, Malabar Simpson DD, Curry SJ (Eds) (1997) Drug abuse treatment outcome study DATOS. Psychol Addict Behav 11 (special issue)
Simpson DD, Joe GW, Dansereau DF, Chatham LR (1997) Strategies for improving methadone treatment process and outcomes. J Drug Issues 27:239–260
Stitzer ML, Iguchi MY, Felch LJ (1992) Contingent take-home incentive: effects on drug use of methadone. J Consult Clin Psychol 60:927–934
Strang J, Gossop M (1996 ) Heroin prescribing in the British system: a historical review. Europ Addict Res 2:185–193
Svikis DS, Lee JH, Haug NA, Stitzer ML (1997) Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Depend 48:33–41
Tennant FS, Rawson RA, Pumphrey E, Seecof R (1986) Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM). J Subst Abuse Treat 3:195–202
Uchtenhagen A, Zimmer-Höfler D (1985) Heroinabhängige und ihre normalen Altersgenossen. Herkunft, Lebenssituation, Zweijahresverlauf im Quervergleich. Haupt, Bern
Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blättler R, Pfeifer S (1999) Prescription of narcotics for heroin addicts. Main results of the Swiss National Cohort Study. Karger, Basel
Verthein U, Degkwitz P, Haasen C, Raschke P, Krausz M (1996) Die Substitutionsbehandlung Opiatabhängiger mit Codein/Dihydrocodein und Methadon - ein Kontrollgruppenvergleich. Sucht 42:108–115
Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE (1994) Clinical pharmacology of buprenorphine. Ceiling effects at high doses . Clin Pharmacol Ther 55:569–580
Ward J, Mattick R, Hall W (1998) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam
Woody GE, McLellan AT, Luborsky LO, Brien CP (1995) Psychotherapy in Community methadone programs: a Validation study. Am J Psychiatry 152:1302–1308
WHO (1989) Options for the use of methadone in the treatment of drug dependence. WHO, Geneva
WHO (1998) WHO expert committee on drug dependence, 3rd report. WHO, Geneva
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Uchtenhagen, A. (2000). Substitutionsbehandlung der Opiatabhängigkeit. In: Helmchen, H., Lauter, H., Henn, F., Sartorius, N. (eds) Erlebens- und Verhaltensstörungen, Abhängigkeit und Suizid. Psychiatrie der Gegenwart, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59627-8_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-59627-8_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65803-0
Online ISBN: 978-3-642-59627-8
eBook Packages: Springer Book Archive